用于测定人血浆和尿液中一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮的高效液相色谱法。 - Suppr | 超能文献

High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine.

作者信息

Miyamoto G, Sasabe H, Odomi M, Shimizu T

出版信息

J Chromatogr. 1985 Mar 22;338(2):450-5. doi: 10.1016/0378-4347(85)80120-1.

DOI:10.1016/0378-4347(85)80120-1

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine.用于测定人血浆和尿液中一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮的高效液相色谱法。

J Chromatogr. 1985 Mar 22;338(2):450-5. doi: 10.1016/0378-4347(85)80120-1.

2

Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212).

Arzneimittelforschung. 1984;34(3A):334-41.

3

[Solid phase clean-up and determination of vesnarinone in plasma by high performance liquid chromatography].

Hua Xi Yi Ke Da Xue Xue Bao. 1992 Mar;23(1):106-9.

4

Method of analysis of the new cardiotonic agent, MDL 19,205, in plasma and urine and its application in a dog pharmacokinetic study.

J Chromatogr. 1983 Dec 9;278(2):379-85. doi: 10.1016/s0378-4347(00)84797-0.

5

LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine.

J Pharm Biomed Anal. 1999 Jan;18(6):1037-45. doi: 10.1016/s0731-7085(98)00194-0.

6

Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone and related compounds.正性肌力药物的研究。I. 3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮及相关化合物的合成

Chem Pharm Bull (Tokyo). 1984 Jun;32(6):2100-10. doi: 10.1248/cpb.32.2100.

7

High-performance liquid chromatographic method for the determination of adibendan in plasma and urine.高效液相色谱法测定血浆和尿液中的阿地苯旦

J Chromatogr. 1987 Nov 27;422:346-52. doi: 10.1016/0378-4347(87)80474-7.

8

Metabolism of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) in the rat, mouse, dog, monkey and human.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮（OPC-8212）在大鼠、小鼠、犬、猴及人体内的代谢

Xenobiotica. 1988 Oct;18(10):1143-55. doi: 10.3109/00498258809042237.

9

Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)及其溶剂环丁砜对大鼠、豚鼠和犬离体心脏标本的影响。

Arzneimittelforschung. 1984;34(3A):359-63.

10

Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.新型强心剂3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮（OPC-8212）对强心活性和冠状动脉血流动力学的影响。

Arzneimittelforschung. 1984;34(3A):355-9.

引用本文的文献

1

Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity.口服OPC-8212治疗充血性心力衰竭：血流动力学改善及运动能力增强。

Heart Vessels. 1986;2(3):166-71. doi: 10.1007/BF02128143.